William Garrett Nichols, Chief Medical Officer at Candel Therapeutics, Inc. (CADL), sold 27,870 shares at $4.56 ($127K) on 2024-11-29, disclosed to the SEC on 2024-12-03.
Open-market sale of $127k CADL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.56 | 13,935 | $64K | 50.0% |
| 2 | $4.56 | 13,935 | $64K | 50.0% |
| Total | $4.56 avg | 27,870 | $127K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $794K | — | Filing → |
| CADL | SELL | 2025-01-17 | $151K | — | Filing → |
| CADL | SELL | 2025-01-10 | $178K | — | Filing → |